These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 11223008)

  • 1. Comparative effects of scopolamine and quinpirole on the striatal fos expression induced by stimulation of D(1) dopamine receptors in the rat.
    Wirtshafter D; Asin KE
    Brain Res; 2001 Mar; 893(1-2):202-14. PubMed ID: 11223008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactive effects of stimulation of D1 and D2 dopamine receptors on fos-like immunoreactivity in the normosensitive rat striatum.
    Wirtshafter D; Asin KE
    Brain Res Bull; 1994; 35(1):85-91. PubMed ID: 7953762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions between D1 and muscarinic receptors in the induction of striatal c-fos in rats depleted of dopamine as neonates.
    Sandstrom MI; Sarter M; Bruno JP
    Brain Res Dev Brain Res; 1996 Oct; 96(1-2):148-58. PubMed ID: 8922677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The atypical dopamine D1 receptor agonist SKF 83959 induces striatal Fos expression in rats.
    Wirtshafter D; Osborn CV
    Eur J Pharmacol; 2005 Dec; 528(1-3):88-94. PubMed ID: 16324697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactive effects of stimulation of D1 and D2 dopamine receptors on Fos expression in the lateral habenula.
    Wirtshafter D; Krebs JC
    Brain Res; 1997 Mar; 750(1-2):245-50. PubMed ID: 9098550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quinpirole attenuates striatal c-fos induction by 5-HT, opioid and muscarinic receptor agonists.
    Cook DF; Wirtshafter D
    Eur J Pharmacol; 1998 May; 349(1):41-7. PubMed ID: 9669494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Striatal Fos expression is indicative of dopamine D1/D2 synergism and receptor supersensitivity.
    LaHoste GJ; Yu J; Marshall JF
    Proc Natl Acad Sci U S A; 1993 Aug; 90(16):7451-5. PubMed ID: 8102797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Compartmentally specific effects of quinpirole on the striatal Fos expression induced by stimulation of D1-dopamine receptors in intact rats.
    Wirtshafter D; Schardt G; Asin KE
    Brain Res; 1997 Oct; 771(2):271-7. PubMed ID: 9401747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The dopamine D1 receptor agonist, but not the D2 receptor agonist, induces gene expression of Homer 1a in rat striatum and nucleus accumbens.
    Yamada H; Kuroki T; Nakahara T; Hashimoto K; Tsutsumi T; Hirano M; Maeda H
    Brain Res; 2007 Feb; 1131(1):88-96. PubMed ID: 17169339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quinpirole attenuates the striatal fos expression induced by escape behavior.
    Struthers WM; Wirtshafter D
    Brain Res; 1998 Mar; 785(2):347-50. PubMed ID: 9518687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of repeated dopamine D1 receptor stimulation on rotation and c-fos expression.
    Asin KE; Wirtshafter D
    Eur J Pharmacol; 1993 Apr; 235(1):167-8. PubMed ID: 8100194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Muscarinic receptor blockade attenuates reserpine-mediated Fos induction in the rat striatopallidal pathway.
    Pollack AE; Angerer MR
    Brain Res; 2005 Oct; 1058(1-2):189-92. PubMed ID: 16153612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Scopolamine augments c-fos and zip/268 messenger RNA expression induced by the full D(1) dopamine receptor agonist SKF-82958 in the intact rat striatum.
    Wang JQ; McGinty JF
    Neuroscience; 1996 Jun; 72(3):601-16. PubMed ID: 8861055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic interaction between an adenosine antagonist and a D1 dopamine agonist on rotational behavior and striatal c-Fos induction in 6-hydroxydopamine-lesioned rats.
    Pollack AE; Fink JS
    Brain Res; 1996 Dec; 743(1-2):124-30. PubMed ID: 9017239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopaminergic and muscarinic regulation of striatal enkephalin and substance P messenger RNAs following striatal dopamine denervation: effects of systemic and central administration of quinpirole and scopolamine.
    Nisenbaum LK; Kitai ST; Gerfen CR
    Neuroscience; 1994 Nov; 63(2):435-49. PubMed ID: 7534387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Muscarinic, adenosine A(2) and histamine H(3) receptor modulation of haloperidol-induced c-fos expression in the striatum and nucleus accumbens.
    Hussain N; Flumerfelt BA; Rajakumar N
    Neuroscience; 2002; 112(2):427-38. PubMed ID: 12044460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Time dependence and role of N-methyl-D-aspartate glutamate receptors in the priming of D2-mediated rotational behavior and striatal Fos expression in 6-hydroxydopamine lesioned rats.
    Pollack AE; Strauss JB
    Brain Res; 1999 May; 827(1-2):160-8. PubMed ID: 10320705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rotation and striatal c-fos expression after repeated, daily treatment with selective dopamine receptor agonists and levodopa.
    Asin KE; Bednarz L; Nikkel A; Perner R
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1483-90. PubMed ID: 7791123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological mechanisms mediating phencyclidine-induced apoptosis of striatopallidal neurons: the roles of glutamate, dopamine, acetylcholine and corticosteroids.
    Griffiths MR; Cooper AJ; Barber DJ; Mitchell IJ
    Brain Res; 2000 Feb; 855(1):1-10. PubMed ID: 10650124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quinpirole attenuates the striatal immediate early gene expression, but not the hyperactivity, induced by the serotonin agonist RU-24969.
    Cook DF; Wirtshafter D
    Brain Res; 2000 Jan; 852(2):247-54. PubMed ID: 10678749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.